CSF2-dependent monocyte education in the pathogenesis of ANCA-induced glomerulonephritis (2022) Rousselle A, Sonnemann J, Amann KU, Mildner A, Lodka D, Kling L, Bieringer M, et al. Journal article Key interactions in the trimolecular complex consisting of the rheumatoid arthritis-associated DRB1*04:01 molecule, the major glycosylated collagen II peptide and the T-cell receptor (2022) Ge C, Weisse S, Xu B, Dobritzsch D, Viljanen J, Kihlberg J, Do NN, et al. Journal article Sequential rituximab and mepolizumab in eosinophilic granulomatosis with polyangiitis (EGPA): a European multicentre observational study. (2022) Bettiol A, Urban ML, Bello F, Fiori D, Mattioli I, Lopalco G, Iannone F, et al. Journal article Ageing and interferon gamma response drive the phenotype of neutrophils in the inflamed joint (2022) Grieshaber-Bouyer R, Exner T, Hackert NS, Radtke FA, Jelinsky SA, Halyabar O, Wactor A, et al. Journal article Response to: 'Correspondence on 'Glucocorticoid-induced relapse of COVID-19 in a patient with sarcoidosis'' by Jeny et al. (2022) Györfi AH, Schett G, Distler J Journal article Epigenetic profiling of twins identify repression of KLF4 as a novel pathomechanism in systemic sclerosis (2021) Distler J, O'Reilly S Journal article, Editorial Efficacy and safety of guselkumab in patients with active psoriatic arthritis who are inadequate responders to tumour necrosis factor inhibitors: results through one year of a phase IIIb, randomised, controlled study (COSMOS) (2021) Coates LC, Gossec L, Theander E, Bergmans P, Neuhold M, Karyekar CS, Shawi M, et al. Journal article Higher serum levels of short-chain fatty acids are associated with non-progression to arthritis in individuals at increased risk of RA (2021) Martinsson K, Dürholz K, Schett G, Zaiss M, Kastbom A Journal article Efficacy and safety of SARS-CoV-2 revaccination in non-responders with immune-mediated inflammatory disease (2021) Simon D, Tascilar K, Fagni F, Schmidt K, Krönke G, Kleyer A, Ramming A, et al. Journal article Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease (2021) Haberman RH, Herati RS, Simon D, Samanovic M, Blank RB, Tuen M, Koralov SB, et al. Journal article